Cell Surface Markers Market, By Product Type (Flow Cytometers, Hematology Analyzers, Reagents and Kits), By Application (Disease Diagnosis and identification, Research/Drug Discovery), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jul 2023

Code : CMI3912

Pages :160

Formats :

Excel and PDF

Industry : Medical Devices

Market News

Global Cell Surface Markers Market: Key Developments

On March 14, 2022, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a China-based global leading medical solution provider, launched the new BC-700 Series, a revolutionary hematology analyzer series that incorporates both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests. This series, including two open vial models BC-700/BC-720 and two autoloader models BC-760/BC-780, is designed to empower medium-volume laboratories with advanced diagnostics technologies that are applied in the premium products. Such launch of more efficient products can drive market growth.

On January 2, 2023, Diatron, a Europe-based Laboratory equipment supplier, announced the launch of Aquarius 3, its latest in vitro diagnostic (IVD) hematology analyzer for Complete Blood Count testing. Aquarius 3 will be the first in a new family of hematology analyzers from Diatron. Evolving from the Abacus 380, Diatron’s flagship analyzer, the Aquarius 3 incorporates similar robust counting technology but is equipped with new features to improve operability and connectivity, allowing it to adapt to diverse environments for the benefit of both customers and users alike.

On May 4, 2021, Beckman Coulter Inc., U.S. based global science and technology company, launched next-generation CytoFLEX SRT benchtop cell sorter. It can sort, and feature expanded laser and color options for use in labs of all sizes. The CytoFLEX SRT is a benchtop cell sorter and offers up to four lasers and 17 detection channels to help accelerate answers in genomics and immune-phenotyping workflows.

On May 18, 2023, Sysmex Corporation, a Japan-based health care company, announced launch of its Clinical Flow Cytometry System, which combines the Flow Cytometer XF-1600, Sample Preparation System PS-10, antibody reagents and other related products. The system makes it possible for laboratories to automate the entire testing process, from sample preparation to the reporting of measurement results in clinical Ferric carboxymaltose (FCM) testing. This achieves higher efficiency and standardization of testing and reduces the burden placed on clinical technologists, allowing them to focus on the more technically demanding analysis of testing results.